Neuropeptides as attractants of immune cells in the brain and their distinct signaling

Advances in Neuroimmune Biology

Volumn 1, Issue 1, 2011, Pages 53-62

  Noda, Mami ^a,b   Ifuku, Masataka ^a   Okuno, Yuko ^a   Beppu, Kaoru ^a   Mori, Yuki ^a   Naoe, Satoko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

ATP; Microglia; migration; neuropeptides

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENOSINE TRIPHOSPHATE; ALANINE; ANGIOTENSIN II; BRADYKININ; CHEMOATTRACTANT; ENDOTHELIN; GALANIN; GAMMA INTERFERON; GLYCINE; INOSITOL 1,4,5 TRISPHOSPHATE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE; NEUROTENSIN; POTASSIUM CHANNEL; PURINERGIC P2X RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; BRAIN CELL; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL MIGRATION; CELL MOTILITY; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS; EXTRACELLULAR CALCIUM; IMMUNOCOMPETENT CELL; MICROGLIA; NEGATIVE FEEDBACK; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SODIUM CALCIUM EXCHANGE; SODIUM TRANSPORT;

EID: 84860179230     PISSN: 1878948X     EISSN: 18789498     Source Type: Journal    
DOI: 10.3233/NIB-2011-005     Document Type: Article

References (71)

1. Kim SU, de Vellis J. Microglia in health and disease. J Neu-rosci Res. 2005; 81(3): 302.
2. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996; 19(8): 312.
3. Perry VH, Andersson PB, Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 1993; 16(7): 268.
4. 2+signaling and the microvasculature in experimental mice models of Alzheimer's disease. Ann N Y Acad Sci. 2007; 1097: 40.
5. Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci. 2005; 6(8): 626.
6. Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, Inoue K. et al. Extracellular ATP orADP induce chemotaxisofcultured microglia through Gi/o-coupled P2Y receptors. J Neurosci. 2001; 21(6): 1975.
7. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005; 8(6): 752.
8. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G. et al. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci. 2003; 23(4): 1398.
9. Takayama N, Ueda H. Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia. J Neurosci. 2005; 25(2): 430.
10. Rappert A, Biber K, Nolte C, Lipp M, Schubel A, Lu B. et al. Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl-current and chemotaxis in murine microglia. J Immunol. 2002; 168(7): 3221.
11. + channels for lysophosphatidic acid-induced microglial migration. Eur J Neurosci. 2004; 19(6): 1469.
12. Liu GJ, Nagarajah R, Banati RB, Bennett MR. Glutamate induces directed chemotaxis of microglia. Eur J Neurosci. 2009; 29(6): 1108.
13. Farber K, Pannasch U, Kettenmann H. Dopamine and nora-drenaline control distinct functions in rodent microglial cells. Mol Cell Neurosci. 2005; 29(1): 128.
14. 2+ exchanger.JNeurosci. 2007; 27(48): 13065.
15. Schwab A. Function and spatial distribution of ion channels and transporters in cell migration. Am J Physiol Renal Phys-iol. 2001; 280(5): F739.
16. Schwab A. Ion channels and transporters on the move. News Physiol Sci. 2001; 16: 29.
17. Griebel G. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?. Pharmacol Ther. 1999; 82(1): 1.
18. Holmes A, Heilig M, Rupniak NM, Steckler T, Griebel G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci. 2003; 24(11): 580.
19. Hokfelt T, Broberger C, Xu ZQ, Sergeyev V, Ubink R, Diez M. Neuropeptides-an overview. Neuropharmacology. 2000; 39(8): 1337.
20. Chao J, Chao L, Swain CC, Tsai J, Margolius HS. Tissue kallikrein in rat brain and pituitary: regional distribution and estrogen induction in the anterior pituitary. Endocrinology. 1987; 120(2): 475.
21. Raidoo DM, Bhoola KD. Pathophysiology of the kallikrein-kinin system in mammalian nervous tissue. Pharmacol Ther. 1998; 79(2): 105.
22. Scicli AG, Forbes G, Nolly H, Dujovny M, Carretero OA. Kallikrein-kinins in the central nervous system. Clin Exp Hypertens A. 1984; 6(10-11): 1731.
23. Walker K, Perkins M, Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int. 1995; 26(1): 1.
24. Noda M, Kettenmann H, Wada K. Anti-inflammatory effects of kinins via microglia in the central nervous system. Biol Chem. 2006; 387(2): 167.
25. Noda M, Kariura Y, Pannasch U, Nishikawa K, Wang L, Seike T. et al. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem. 2007; 101(2): 397.
26. Yasuyoshi H, Kashii S, Zhang S, Nishida A, Yamauchi T, Honda Y. et al. Protective effect of bradykinin against glu-tamate neurotoxicity in cultured rat retinal neurons. Invest Ophthalmol Vis Sci. 2000; 41(8): 2273.
27. Lehmberg J, Beck J, Baethmann A, Uhl E. Bradykinin antagonists reduce leukocyte-endothelium interactions after global cerebral ischemia. J Cereb Blood Flow Metab. 2003; 23(4): 441.
28. Schulze-Topphoff U, Prat A, Prozorovski T, Siffrin V, Paterka M, Herz J. et al. Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitmentto the central nervous system. Nat Med. 2009; 15(7): 788.
29. Noda M, Kariura Y, Amano T, Manago Y, Nishikawa K, Aoki S. et al. Expression and function of bradykinin receptors in microglia. Life Sci. 2003; 72(14): 1573.
30. Stephens GJ, Cholewinski AJ, Wilkin GP, Djamgoz MB. Calcium-mobilizing and electrophysiological effects of bradykinin on cortical astrocyte subtypes in culture. Glia. 1993; 9(4): 269.
31. Gimpl G, Walz W, Ohlemeyer C, Kettenmann H. Bradykinin receptors in cultured astrocytes from neonatal rat brain are linked to physiological responses. Neurosci Lett. 1992; 144(1-2): 139.
32. Hosli L, Hosli E, Kaeser H, Lefkovits M. Colocalization of receptors for vasoactive peptides on astrocytes of cultured rat spinal cord and brain stem: electrophysiological effects of atrial and brain natriuretic peptide, neuropeptide Y and bradykinin. Neurosci Lett. 1992; 148(1-2): 114.
33. Lin WW, Chuang DM. Regulation of bradykinin-induced phosphoinositide turnover in cultured cerebellar astrocytes: possible roleofprotein kinaseC.Neurochem Int. 1992; 21(4): 573.
34. Hsieh HL, Yen MH, Jou MJ, Yang CM. Intracellular signalings underlying bradykinin-induced matrix metallo-proteinase-9 expression in rat brain astrocyte-1. Cell Signal. 2004; 16(10): 1163.
35. Hsieh HL, Wu CY, Hwang TL, Yen MH, Parker P, Yang CM. BK-induced cytosolic phospholipase A2 expression via sequential PKC-delta, p42/p44 MAPK, and NF-kappaB activation in rat brain astrocytes. J Cell Physiol. 2006; 206(1): 246.
36. Hsieh HL, Wang HH, Wu CY, Jou MJ, Yen MH, Parker P. et al. BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes. Cell Signal. 2007; 19(2): 330.
37. Schwaninger M, Sallmann S, Petersen N, Schneider A, Prinz S, Libermann TA. et al. Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-kappaB. J Neurochem. 1999; 73(4): 1461.
38. Liu HT, Akita T, Shimizu T, Sabirov RZ, Okada Y. Bradykinin-induced astrocyte-neuron signalling: glutamate release is mediated by ROS-activated volume-sensitive outwardly rectifying anion channels. J Physiol. 2009; 587(Pt 10): 2197.
39. Fleisher-Berkovich S, Filipovich-Rimon T, Ben-Shmuel S, Hulsmann C, Kummer MP, Heneka MT. Distinct modulation of microglial amyloid beta phagocytosis and migration by neuropeptides (i). J Neuroinflammation. 2010; 7: 61.
40. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005; 308(5726): 1314.
41. Fetler L, Amigorena S. Neuroscience. Brain under surveillance: the microglia patrol. Science. 2005; 309(5733): 392.
42. Hanisch UK. Microglia as a source and target of cytokines. Glia. 2002; 40(2): 140.
43. Liu Y, Shenouda D, Bilfinger TV, Stefano ML, Magazine HI, Stefano GB. Morphine stimulates nitric oxide release from invertebrate microglia. Brain Res. 1996; 722(1-2): 125.
44. Saura J, Angulo E, Ejarque A, Casado V, Tusell JM, Moratalla R. et al. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J Neu-rochem. 2005; 95(4): 919.
45. Stefano GB, Liu Y, Goligorsky MS. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immuno-cytes, microglia, and human monocytes. J Biol Chem. 1996; 271(32): 19238.
46. Moller T, Kann O, Verkhratsky A, Kettenmann H. Activation of mouse microglial cells affects P2 receptor signaling. Brain Res. 2000; 853(1): 49.
47. Light AR, Wu Y, Hughen RW, Guthrie PB. Purinergic receptors activating rapid intracellular Ca increases in microglia. Neuron Glia Biol. 2006; 2(2): 125.
48. + conductance in cultured microglial cells from mouse brain. J Neurosci. 1993; 13(10): 4403.
49. Noda M, Sasaki K, Ifuku M, Wada K. Multifunctional effects of bradykinin on glial cells in relation to potential anti-inflammatory effects. Neurochem Int. 2007; 51(2-4): 185.
50. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther. 2001; 298(1): 249.
51. 2+ exchange activity by interferon-gamma in cultured rat microglia. J Neurochem. 2004; 90(4): 784.
52. Ohsawa K, Irino Y, Nakamura Y, Akazawa C, Inoue K, Kohsaka S. Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia. 2007; 55(6): 604.
53. Tatemoto K, Rokaeus A, Jornvall H, McDonald TJ, Mutt V. Galanin-a novel biologically active peptide from porcine intestine. FEBS Lett. 1983; 164(1): 124.
54. Brecht S, Buschmann T, Grimm S, Zimmermann M, Herde-gen T. Persisting expression of galanin in axotomized mamillary and septal neurons of adult rats labeled for c-Jun and NADPH-diaphorase. Brain Res Mol Brain Res. 1997; 48(1): 7.
55. Cortes R, Villar MJ, Verhofstad A, Hokfelt T. Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study. Proc Natl Acad Sci USA. 1990; 87(19): 7742.
56. Hokfelt T, Wiesenfeld-Hallin Z, Villar M, Melander T. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett. 1987; 83(3): 217.
57. Hokfelt T, Tatemoto K. Galanin-25 years witha multitalented neuropeptide. Cell Mol Life Sci. 2008; 65(12): 1793.
58. Branchek TA, Smith KE, Gerald C, Walker MW. Galanin receptor subtypes. Trends Pharmacol Sci. 2000; 21(3): 109.
59. Perez SE, Wynick D, Steiner RA, Mufson EJ. Distribution of galaninergic immunoreactivity in the brain of the mouse. J Comp Neurol. 2001; 434(2): 158.
60. Gustafson EL, Smith KE, Durkin MM, Gerald C, Branchek TA. Distribution of a rat galanin receptor mRNA in rat brain. Neuroreport. 1996; 7(4): 953
61. Su Y, Ganea D, Peng X, Jonakait GM. Galanin down-regulates microglial tumor necrosis factor-alpha production by a post-transcriptional mechanism. J Neuroimmunol. 2003; 134(1-2): 52.
62. Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF. Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci USA. 1994; 91(21): 9780.
63. + channels. J Biol Chem. 1998; 273(36): 23321.
64. Wang S, Hashemi T, Fried S, Clemmons AL, Hawes BE. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry. 1998; 37(19): 6711.
65. Wittau N, Grosse R, Kalkbrenner F, Gohla A, Schultz G, Gudermann T. The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins. Oncogene. 2000; 19(37): 4199.
66. 2+ mobilization in galanin-induced microglial migration. J Neurochem. 2011; 117(1): 61.
67. Hardy PO, Diallo TO, Matte C, Descoteaux A. Roles of phos- phatidylinositol 3-kinase and p38 mitogen-activated protein kinase in the regulation of protein kinase C-alpha activation in interferon-gamma-stimulated macrophages. Immunology. 2009; 128(1 Suppl): e652.
68. Van Wagoner NJ, O'Keefe GM, Benveniste EN. Kinase inhibitors abrogate IFN-gamma-induced class II transactiva-tor and class IIMHC gene expressioninastroglioma cell lines. J Neuroimmunol. 1998; 85(2): 174.
69. Elliott-Hunt CR, Marsh B, Bacon A, Pope R, Vanderplank P, Wynick D. Galanin acts as a neuroprotective factor to the hippocampus. Proc Natl Acad Sci USA. 2004; 101(14): 5105.
70. Farber K, Kettenmann H. Purinergic signaling and microglia. Pflugers Arch. 2006; 452(5): 615.
71. Farber K, Markworth S, Pannasch U, Nolte C, Prinz V, Kronenberg G. et al. The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia. 2008; 56(3): 331.